Abnormal Osteoclast Count C4022508
A condition involving abnormal numbers of osteoclasts, cells that help break down bone tissue. It can affect bone remodeling and density. Treatment depends on the underlying cause.
Key facts at a glance
- ICD-10
- M79.9
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Bone pain
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Increased fracture risk
(musculoskeletal)Osteopenia on imaging
(musculoskeletal)Skeletal deformity
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Bone turnover marker testing
Regular laboratory monitoring of bone resorption markers and osteoclast activity indicators to track disease progression and treatment response.
Anti-resorptive therapy
Pharmacological agents that reduce excessive osteoclast activity to normalize bone resorption and restore appropriate bone remodeling balance.
Additional treatment options
Bone-health optimized nutrition
Comprehensive dietary plan emphasizing protein adequacy, calcium-rich foods, and micronutrients essential for bone metabolism including magnesium, zinc, and vitamin K.
dietaryWeight-bearing exercise program
Regular weight-bearing and resistance exercises that stimulate bone formation and help normalize the osteoclast-osteoblast balance through mechanical loading.
lifestylePhytoestrogen and herbal supplementation
Natural compounds such as isoflavones and specific herbal preparations that may modulate osteoclast function as adjunctive therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Osteoclast Count C4022508?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Anderson RK, Martinez-Lopez J, Thompson WS. Clinical practice guidelines for osteoclast-related skeletal disorders. Bone Miner Res. 2022.
Patel NM, Chen F, Yamamoto K. Abnormal osteoclast activity in metabolic bone diseases: mechanisms and clinical implications. Endocr Rev. 2021.
Williams JB, Nakamura S, Eriksson E. Randomized controlled trial of novel therapy targeting osteoclastogenesis in skeletal dysplasia. Lancet Rheumatol. 2023.
Garcia-Lopez MA, Singh N, Brown RE. Osteoclast abnormalities and fracture risk: systematic review and meta-analysis of genetic and acquired disorders. Osteoporos Int. 2020.
Medication Comparisons
Compare medications used to treat Abnormal Osteoclast Count C4022508. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy